Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Improving Brain Tumor Segmentation at the Edge

Intel’s Abhishek Khowala, principal health AI engineer, and Séverine Habert, AI engineering manager, discuss some of the enhancements in brain tumor segmentation for enabling diagnosis. While most brain tumors are benign, early detection is critical for the best treatment options and outcomes. Assessing a diagnosis starts with MRI 2D and 3D imaging. Segmentation of…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Intel on MarketScale.

Share

Intel’s Abhishek Khowala, principal health AI engineer, and Séverine Habert, AI engineering manager, discuss some of the enhancements in brain tumor segmentation for enabling diagnosis.

While most brain tumors are benign, early detection is critical for the best treatment options and outcomes. Assessing a diagnosis starts with MRI 2D and 3D imaging. Segmentation of the brain tumor – or separating the tumor from normal brain tissues – is essential to identifying three key factors to allow doctors to move forward:

  1. Is the tumor benign or malignant?
  2. The approximate tumor size and location.
  3. Plan out the treatment options.

“We need to segment out the tumor from the rest of the tissues around it,” Khowala says. “For that, there is the unit model. And that architecture works with fewer amounts of data yet provides a clearer segmentation result.”

The brain tumor segmentation (BraTS) combined with OpenVINO™ toolkit could optimize MRI results during tumor detection and monitoring. “Since this is something that has to happen worldwide, we need to deploy it at scale,” Khowala explains. Scaling requires overcoming a few challenges. Utilizing OpenVINO erases issues of high-cost GPU required for deploying AI solutions or perceived performance limitations of common frameworks such as PyTorch or TensorFlow. “Brain tumor segmentation is a perfect example of applying the most common architecture and using it for multiple devices from edge to handheld devices,” Habert adds.

For optimized AI, the provided data must be robust, which is not an easy task. According to Khowala, Expert radiologists are required to interpret the MRI images to get to the ground truth data. BraTS helps predict results and compare accuracy with provided ground truth results using the Sørensen–Dice coefficient datasets. Once the data is available, modeling can take place and assist medical professionals in their diagnosis.

Learn more about brain tumor segmentation solutions by connecting with Abhishek Khowala and Séverine Habert on LinkedIn or visit:

https://www.intel.com/content/www/us/en/healthcare-it/healthcare-overview.html.

Subscribe to this channel on Apple Podcasts, Spotify, and Google Podcasts to hear more from the Intel Internet of Things Group.

Intel

Part of this channel

Intel

Silicon and AI platforms powering enterprise and edge compute.

Visit the channel →

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Clinical AI, specialty pharmacy, and consolidation: what's reshaping healthcare operations right now

Clinical AI, specialty pharmacy, and consolidation: what's reshaping healthcare operations right now

The healthcare industry is being reshaped by advancements in AI, the direct involvement of companies like OpenAI with hospitals, and the increasing trend of mergers and acquisitions in specialty pharmacy. Nurses are actively participating in the design of AI tools, emphasizing the collaborative nature of these technological advancements. These changes are expected to have significant implications for health system operations.

  • 01Nurses are co-designing AI tools for healthcare.
  • 02OpenAI is engaging directly with hospitals.
  • 03Specialty pharmacy mergers and acquisitions are on the rise.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub